Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    FDA Approved Therapy for SOD1 Associated ALS

    FDA Approved Therapy for SOD1 Associated ALS

    FromNeurology Minute

    Start listeningView podcast show

    FDA Approved Therapy for SOD1 Associated ALS

    FromNeurology Minute

    ratings:
    Length:
    3 minutes
    Released:
    May 19, 2023
    Format:
    Podcast episode

    Description

    Dr. Suma Babu discusses a new approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.  Show references: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
    Released:
    May 19, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.